Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Li MM"'
Publikováno v:
OncoTargets and Therapy, Vol Volume 13, Pp 4999-5016 (2020)
Peng-Yu Chen, Xiao-Dong Li, Wei-Ning Ma, Han Li, Miao-Miao Li, Xin-Yu Yang, Shao-Yi Li Department of Neurosurgery, Shengjing Hospital Affiliated to China Medical University, Shenyang, People’s Republic of ChinaCorrespondence: Shao-Yi LiDepartment o
Externí odkaz:
https://doaj.org/article/9d7f0c970d4b44768359cc6ace587fc5
Publikováno v:
OncoTargets and Therapy, Vol 2016, Iss Issue 1, Pp 489-502 (2016)
Wang Jing,1,2,* Miaomiao Li,3,* Yan Zhang,2 Feifei Teng,2 Anqin Han,2 Li Kong,2 Hui Zhu2 1Weifang Medical University, Weifang, Shandong Province, People’s Republic of China; 2Department of Radiation Oncology, Shandong Cancer Hospital and Institute,
Externí odkaz:
https://doaj.org/article/9f612b51ce39437faedb69803c101663
Publikováno v:
OncoTargets and Therapy, Vol 2015, Iss default, Pp 893-898 (2015)
Qianqian Zhang,1 Zhehai Wang,2 Jun Guo,2 Liyan Liu,2 Xiao Han,2 Minmin Li,1 Shu Fang,1 Xiang Bi,1 Ning Tang,1 Yang Liu1 1School of Medicine and Life Sciences, Shandong Academy of Medical Sciences, University of Jinan, 2Department of Oncology, Shandon
Externí odkaz:
https://doaj.org/article/21094908e4564948b33a5d0548329f2d
Autor:
Li MM, Wang ZH, Guo J, Liu J, Li CZ, Liu L, Shi H, Liu LY, Li HH, Xie C, Zhang X, Sun WW, Fang S, Bi X
Publikováno v:
OncoTargets and Therapy, Vol 2014, Iss default, Pp 1653-1661 (2014)
Minmin Li,1 Zhehai Wang,2 Jun Guo,2 Jie Liu,2 Changzheng Li,2 Lin Liu,2 Huan Shi,2 Liyan Liu,2 Huihui Li,2 Chao Xie,2 Xia Zhang,2 Wenwen Sun,1 Shu Fang,1 Xiang Bi11School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical
Externí odkaz:
https://doaj.org/article/a564b88e4bd54bda87ea8df342e34d35
Autor:
Fang S, Wang ZH, Guo J, Liu J, Li CZ, Liu L, Shi H, Liu LY, Li HH, Xie C, Zhang X, Sun WW, Li MM
Publikováno v:
OncoTargets and Therapy, Vol 2014, Iss default, Pp 1185-1193 (2014)
Shu Fang,1 Zhehai Wang,2 Jun Guo,2 Jie Liu,2 Changzheng Li,2 Lin Liu,2 Huan Shi,2 Liyan Liu,2 Huihui Li,2 Chao Xie,2 Xia Zhang,2 Wenwen Sun,1 Minmin Li1 1School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences,
Externí odkaz:
https://doaj.org/article/eb2037e5dc6248a3a691c0656300021d
Autor:
Xue Bing MM, Ning Wang MM, Yuhan Li MB, Haitao Sun PhD, Jian Yao PhD, Ruobing Li MM, Zhongyuan Li MM, Aimei Ouyang PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 23 (2024)
Objective We investigated the potential of dual-energy computed tomography (DECT) radiomics in assessing cancer-associated fibroblasts in clear cell renal carcinoma (ccRCC). Methods A retrospective analysis was conducted on 132 patients with ccRCC. T
Externí odkaz:
https://doaj.org/article/ea700c4b6a21493eb5193992b3d0e26c
Autor:
Xuelei Chu PhD, Feiyu Xie PhD, Chengzhi Hou PhD, Xin Zhang MM, Sijia Wang MM, Hongting Xie MM, Chen An MM, Ying Li MM, Leyi Zhao MBBS, Peng Xue PhD, Shijie Zhu PhD
Publikováno v:
Integrative Cancer Therapies, Vol 23 (2024)
Background: Siwu Decoction (SWD) is a well-known classical TCM formula that has been shown to be effective as a basis for preventing and reducing liver metastases (LM). However, the active ingredients and potential molecular mechanisms remain unclear
Externí odkaz:
https://doaj.org/article/08966b4ffd3e4f7a816f4ff754a5dec8
Autor:
Tong Lu MM, Yu Fang MM, Haonan Liu MM, Chong Chen MM, Taotao Li MM, Miao Lu MSN, Daqing Song MB
Publikováno v:
Technology in Cancer Research & Treatment, Vol 23 (2024)
Objectives This two-center study aimed to establish a model for predicting the risk of lymph node metastasis in gastric cancer patients using machine learning (ML) and logistic regression (LR) algorithms, and to evaluate its predictive performance in
Externí odkaz:
https://doaj.org/article/3d8ed1f49a9c4a7a81e5b904124c7ad8
Autor:
Dong Zhao PhD, Dantong Zhu PhD, Fei Cai MM, Mingzhe Jiang PhD, Xuefei Liu PhD, Tingting Li MM, Zhendong Zheng PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Adoptive cell immunotherapy (ACT) is an innovative promising treatment for tumors. ACT is characterized by the infusion of active anti-tumor immune cells (specific and non-specific) into patients to kill tumor cells either directly or indirectly by s
Externí odkaz:
https://doaj.org/article/b1d93d9f1b934470ba73f211a90c6493
Autor:
Xuan Zou MD, Zi-Yi Chen MM, Yu-Han Yang MM, Yu Qiao MD, Shu-Jin He MM, Qiong Li MD, Wei-Li Chen PhD, MD, Xin-Yue Zhang MM, Si-Yu Li MM, Shan-Yan Sha MM, Min-Hao Hu MM, Xi-Yin Zhang MM, Ming-Ju Yang MM, Rui-Ping Wang PhD, Huan-Gan Wu PhD, MD, Yin Shi PhD, MD, Xiao-Hong Xue PhD, MD, Ya-Jie Ji PhD, MD
Publikováno v:
Integrative Cancer Therapies, Vol 22 (2023)
Background: Aromatase inhibitors (AIs) are recommended as the preferred therapy for postmenopausal women with hormone receptor-positive (HR+) breast cancer. As a result, aromatase inhibitor-associated musculoskeletal symptom (AIMSS) have become a maj
Externí odkaz:
https://doaj.org/article/a783e003feaa4fe8bc6ef03f4a9aa884